Insider Transactions in Q4 2021 at Better Therapeutics, Inc. (BTTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2021
|
Risa J Lavizzo Mourey |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$40,000
$4.6 P/Share
|
|
Dec 20
2021
|
Kevin J Appelbaum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+21.05%
|
$4,000
$4.6 P/Share
|
|
Dec 15
2021
|
Kevin J Appelbaum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
750
+21.43%
|
$3,000
$4.71 P/Share
|
|
Dec 15
2021
|
Mark Heinen Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,333
+18.92%
|
$9,332
$4.7 P/Share
|
|
Dec 14
2021
|
Geoffrey M. Parker |
BUY
Open market or private purchase
|
Indirect |
20,000
+27.27%
|
$80,000
$4.94 P/Share
|
|
Dec 14
2021
|
Mark Heinen Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500
+6.12%
|
$2,500
$5.44 P/Share
|
|
Dec 13
2021
|
Andrew J. Armanino |
BUY
Open market or private purchase
|
Indirect |
21,000
+19.57%
|
$105,000
$5.48 P/Share
|
|
Dec 13
2021
|
Mark Heinen Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500
+6.52%
|
$2,500
$5.45 P/Share
|
|
Dec 10
2021
|
Kevin J Appelbaum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+33.33%
|
$5,000
$5.98 P/Share
|
|
Dec 03
2021
|
Elder Granger |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$6,000
$6.66 P/Share
|
|
Dec 03
2021
|
Kevin J Appelbaum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+33.33%
|
$3,000
$6.43 P/Share
|
|
Dec 02
2021
|
Kevin J Appelbaum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+50.0%
|
$3,000
$6.84 P/Share
|
|
Nov 29
2021
|
Andrew J. Armanino |
BUY
Open market or private purchase
|
Indirect |
17,000
+20.65%
|
$102,000
$6.96 P/Share
|
|
Oct 28
2021
|
Mark Heinen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+16.67%
|
-
|
|
Oct 28
2021
|
Andrew J. Armanino |
BUY
Grant, award, or other acquisition
|
Indirect |
48,328
+43.94%
|
-
|
|
Oct 28
2021
|
Andrew J. Armanino |
BUY
Grant, award, or other acquisition
|
Direct |
13,334
+50.0%
|
-
|
|
Oct 28
2021
|
Geoffrey M. Parker |
BUY
Grant, award, or other acquisition
|
Indirect |
33,333
+50.0%
|
-
|
|
Oct 28
2021
|
Suying Liu Director |
BUY
Other acquisition or disposition
|
Indirect |
1,402,500
+50.51%
|
-
|
|
Oct 28
2021
|
Richard H Carmona |
BUY
Grant, award, or other acquisition
|
Direct |
153,619
+50.0%
|
-
|
|
Oct 28
2021
|
David P Perry Executive Chairman |
BUY
Grant, award, or other acquisition
|
Indirect |
10,578,501
+13.43%
|
$105,785,010
$10.0 P/Share
|
|
Oct 28
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
200,000
+1.83%
|
$2,000,000
$10.0 P/Share
|